ROYAL BANK OF CANADA - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 34 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$0148
-52.4%
0.00%
Q2 2023$0
-100.0%
311
-85.5%
0.00%
Q3 2020$6,000
-14.3%
2,152
+0.4%
0.00%
Q2 2020$7,0002,143
+1848.2%
0.00%
Q1 2020$0
-100.0%
110
-38.2%
0.00%
Q3 2019$1,000178
+8800.0%
0.00%
Q3 2018$02
-33.3%
0.00%
Q3 2017$0
-100.0%
3
-100.0%
0.00%
Q2 2013$36,0007,0130.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2018
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$541,7780.01%
Renaissance Technologies 555,763$1,0500.00%
Oakworth Capital, Inc. 3,052$5,7680.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$3540.00%
MORGAN STANLEY 11,274$21,3080.00%
BlackRock Inc. 110,990$209,7710.00%
Bank of New York Mellon Corp 75,268$142,2560.00%
Citadel Advisors 32,400$61,2360.00%
Citadel Advisors 6,400$12,0960.00%
Citadel Advisors 5,933$11,2130.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders